Omeros Corporation (OMER)

P/S ratio as of January 2025 (TTM): N/A

According to Omeros Corporation's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is -3.70. At the end of 2024 the company had a P/S ratio of N/A.

P/S ratio history for Omeros Corporation from 2009 to 2024

PS ratio at the end of each year

Year	P/S ratio	Change
2024	N/A
2023	N/A
2022	N/A
2021	N/A	-100%
2020	11.9	74.73%
2019	6.83	-62.63%
2018	18.3	27.05%
2017	14.4	40.65%
2016	10.2	-76.91%
2015	44.3	-97.18%
2014	> 1000	633.64%
2013	214	859.81%
2012	22.3	14.33%
2011	19.5	-77.25%
2010	85.8	-17.08%
2009	103

P/S ratio for similar companies or competitors

Company	P/S ratio	P/S ratio differencediff.	Country
Eterna Therapeutics ERNA	31.7	N/A	🇺🇸 USA
Genetic Technologies GENE	0.2168	N/A	🇦🇺 Australia
Pfizer PFE	2.51	N/A	🇺🇸 USA
Johnson & Johnson JNJ	3.95	N/A	🇺🇸 USA

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions

P/S ratio for Omeros Corporation (OMER)

P/S ratio as of January 2025 (TTM): N/A